About Us
01/03
ClinflashClinflash Cloud clinical trial digital platform covers more than 10 self-developed clinical trial digital systems
Clinflash EDC
Electronic Data Capture
Electronic Data Capture
Clinflash eCOA
Electronic Clinical Outcome Assessment
Electronic Clinical Outcome Assessment
Clinflash IRT
Randomization and Supply Management
Randomization and Supply Management
Clinflash Safety
Pharmacovigilance Safety Database
Pharmacovigilance Safety Database
Clinflash CTMS
Clinical Trial Management System
Clinical Trial Management System
Clinflash eTMF
Electronic Trial Master File
Electronic Trial Master File
Clinflash eCTD
Electronic Common Technical Document
Electronic Common Technical Document
Clinflash ePAY
Clinical Trial Electronic Payment
Clinical Trial Electronic Payment
Clinflash Coder
Medical and Drug Coding System
Medical and Drug Coding System
Clinflash eSign
Clinical Trial Electronic Signature
Clinical Trial Electronic Signature
Clinflash Trial Bridge
Unified Platform for Participant Engagement
Unified Platform for Participant Engagement
ClinSight
Clinical Trial Insight & Collaboration Platform
Clinical Trial Insight & Collaboration Platform
Clinflash
Pharmacovigilance Service
Pharmacovigilance Service
Clinflash
Randomization and Blinding Service
Randomization and Blinding Service
IRT/RTSM
System Configuration and Management Service
System Configuration and Management Service
Clinflash
Data Management Service
Data Management Service
Clinflash
Biostatistics Service
Biostatistics Service
Clinflash
Licensing Acquisition Service
Licensing Acquisition Service
Clinflash Cloud has been widely used in large-scale registration and post-marketing clinical research at home and abroad, serving more than 3000 leading local and global healthcare companies and CROs, covering innovative drugs, generic drugs, medical devices, in vitro diagnostics and other fields.Clinflash Cloud has been used in 35+ countries and territories, enabling over 10,000 clinical trial programs, including more than 250 pivotal Phase III studies and more than 100 international multicenter studies，providing effective support for global pharmaceutical R&D.
10000+Clinical Research Projects
3000+Pharmaceutical Company and CRO Partners
35+ Countries and Territories Covered
250+Phase III Clinical Studies
60% of Oncology Studies
60% of Oncology Studies
“Partnering with Clinflash to accelerate the process of pharmaceutical innovation!”
About ClinflashThe leading provider of digital solutions and professional services in field of clinical development
Clinflash International Limited (hereinafter referred to as “Clinflash”), as the leading provider of digital solutions and professional services in field of clinical development in China, adheres to the concept of “Striving for Excellence with Customers” to help domestic and foreign pharmaceutical enterprises improve R&D efficiency and effectiveness by providing first-class clinical trial digital platforms and professional services.
“Partnering with Clinflash to accelerate the process of pharmaceutical innovation!”
Empowering global pharmaceutical R&D initiativesThe digital solutions independently developed by Clinflash have been applied in more than 35 countries and regions, providing users around the world with a better choice of digital products.
North AmericaEuropeSouth AmericaAfricaSoutheast AsiaEast AsiaOceania
US*
Canada
Mexico
Clinflash solutions received inspection from following government authorities with no findings in 10+ pivotal studies:U.S. Food and Drug Administration(FDA), China National Medical Products Administration(NMPA), Taiwan Food and Drug Administration(TFDA), Malaysia National Pharmaceutical Regulatory Agency (NPRA), Philippines Food and Drug Administration (PFDA)，Indonesia Badan Pengawas Obat and Makanan (BPOM)，Japan Pharmaceuticals and Medical Devices Agency（PMDA）
2021
Zelgen
PhaseⅡ&Ⅲ
Donafenib.HCCApproved by NMPA(China)
SinoCell Tech
Phase Ⅲ
Recombinant Coagulation FactorVll for lnjection,Hemophilia AApproved by NMPA(China)
20182020202120222023202420252026
Compliance firstcertified by domestic and foreign authorities
Full compliance with national standardsObtaining Level 3 certification for information system security level protectionRated as one of the first batch of DCMM standard implementation pilot enterprises
A national high-tech enterprise
Compliance with international industry requirements21 CFR Part 11GAMP5
CDISC
ICH-E2B
ISO system certificationISO 20000ISO 19001
ISO 27701
ISO 27001
ISO 42001
Honorary Witness
Digital technology enables pharmaceutical innovation with honors
Digital technology enables pharmaceutical innovation with honors
